Insulin aspart, recombinant Subcutaneous and Nitisinone Capsules
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nitisinone Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nitisinone
Brand name: Orfadin, Nityr
Synonyms: Nitisinone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nitisinone Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Nitisinone Tablets
- Insulin aspart, recombinant Subcutaneous-Nitrek
- Insulin aspart, recombinant Subcutaneous-Nitric Oxide
- Insulin aspart, recombinant Subcutaneous-Nitric oxide Inhalation
- Insulin aspart, recombinant Subcutaneous-Nitric oxide inhalation gas
- Nitisinone Capsules-Insulin degludec
- Nitisinone Capsules-Insulin Degludec (U-100) Prefilled Pens
- Nitisinone Capsules-Insulin Degludec (U-100) Vials
- Nitisinone Capsules-Insulin Degludec (U-200) Prefilled Pens
- Nitisinone Capsules-Insulin degludec and liraglutide
- Nitisinone Capsules-Insulin degludec and liraglutide Subcutaneous